|
Presiding Chair
|
Oliver Flint, BMS
|
|
Presiding Chair-Elect
|
Mark Fielden, Amgen
|
|
Chair
|
Mark Fielden, Amgen
|
| Chair-Elect |
Donna Dambach, Genentech |
|
|
Scott Barros, Alnylam
Eric Blomme, Abbott
Martin Dyroff, AstraZeneca
|
|
Chair
|
Kelly Flagella, Genentech
|
| Chair-Elect |
Kevin Leach, Shire |
|
|
Michael Leach, Pfizer
Rafael Ponce, Amgen
Christopher Horvath, Alexion Pharma
Lise Loberg, Abbott
|
|
